BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38184773)

  • 1. Association of Ultrasonography Features of Follicular Thyroid Carcinoma With Tumor Invasiveness and Prognosis Based on WHO Classification and TERT Promoter Mutation.
    Kim MK; Park H; Oh YL; Shin JH; Kim TH; Hahn SY
    Korean J Radiol; 2024 Jan; 25(1):103-112. PubMed ID: 38184773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations.
    Park H; Shin HC; Yang H; Heo J; Ki CS; Kim HS; Kim JH; Hahn SY; Chung YJ; Kim SW; Chung JH; Oh YL; Kim TH
    Mod Pathol; 2022 Feb; 35(2):186-192. PubMed ID: 34497362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection Criteria for Completion Thyroidectomy in Follicular Thyroid Carcinoma Using Primary Tumor Size and TERT Promoter Mutational Status.
    Park H; Heo J; Ki CS; Shin JH; Oh YL; Son YI; Kim JS; Kim SW; Chung JH; Kim TY; Kim TH; Kim JH
    Ann Surg Oncol; 2023 May; 30(5):2916-2925. PubMed ID: 36637642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the diagnostic performance of three ultrasound thyroid nodule risk stratification systems for follicular thyroid neoplasm: K-TIRADS, ACR -TIRADS and C-TIRADS.
    Li HJ; Yang YP; Liang X; Zhang Z; Xu XH
    Clin Hemorheol Microcirc; 2023; 85(4):395-406. PubMed ID: 37694360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Ultrasound in Predicting Tumor Invasiveness in Follicular Variant of Papillary Thyroid Carcinoma.
    Hahn SY; Shin JH; Oh YL; Kim TH; Lim Y; Choi JS
    Thyroid; 2017 Sep; 27(9):1177-1184. PubMed ID: 28699414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can ultrasound systems for risk stratification of thyroid nodules identify follicular carcinoma?
    Castellana M; Piccardo A; Virili C; Scappaticcio L; Grani G; Durante C; Giovanella L; Trimboli P
    Cancer Cytopathol; 2020 Apr; 128(4):250-259. PubMed ID: 31899594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation profiles of follicular thyroid tumors by targeted sequencing.
    Duan H; Liu X; Ren X; Zhang H; Wu H; Liang Z
    Diagn Pathol; 2019 May; 14(1):39. PubMed ID: 31077238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative sonographic features of follicular thyroid carcinoma predict biological behavior: A retrospective study.
    Lai X; Jiang Y; Zhang B; Liang Z; Jiang Y; Li J; Zhao R; Yang X; Zhang X
    Medicine (Baltimore); 2018 Oct; 97(41):e12814. PubMed ID: 30313115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TERT Promoter Mutation Spatial Heterogeneity in a Metastatic Follicular Thyroid Carcinoma: Implications for Clinical Work-Up.
    Stenman A; Hysek M; Jatta K; Bränström R; Darai-Ramqvist E; Paulsson JO; Wang N; Larsson C; Zedenius J; Juhlin CC
    Endocr Pathol; 2019 Sep; 30(3):246-248. PubMed ID: 31154561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the clinicopathological characteristics and genetic alterations of follicular thyroid cancer.
    Song YS; Lim JA; Min HS; Kim MJ; Choi HS; Cho SW; Moon JH; Yi KH; Park DJ; Cho BY; Park YJ
    Eur J Endocrinol; 2017 Dec; 177(6):465-473. PubMed ID: 28864536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic Value of American Thyroid Association Guidelines,American College of Radiology Thyroid Imaging Reporting and Data System,and Chinese Thyroid Imaging Reporting and Data System Alone and Combined With BRAF
    Lin Y; Luo YK; Li J; Ren XY; Wang HW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Dec; 45(6):921-928. PubMed ID: 38173102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer.
    Liu X; Qu S; Liu R; Sheng C; Shi X; Zhu G; Murugan AK; Guan H; Yu H; Wang Y; Sun H; Shan Z; Teng W; Xing M
    J Clin Endocrinol Metab; 2014 Jun; 99(6):E1130-6. PubMed ID: 24617711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of single-nucleotide polymorphism in TERT promoter on follicular thyroid tumor development.
    Hirokawa T; Arimasu Y; Nakazato Y; Chiba T; Fujiwara M; Kamma H
    Pathol Int; 2020 Apr; 70(4):210-216. PubMed ID: 31943533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Stratification in Patients With Follicular Neoplasm on Cytology: Use of Quantitative Characteristics and Sonographic Patterns.
    Wu MH; Chen KY; Hsieh MS; Chen A; Chen CN
    Front Endocrinol (Lausanne); 2021; 12():614630. PubMed ID: 33995270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Implication of World Health Organization Classification in Patients with Follicular Thyroid Carcinoma in South Korea: A Multicenter Cohort Study.
    Jin M; Kim ES; Kim BH; Kim HK; Yi HS; Jeon MJ; Kim TY; Kang HC; Kim WB; Shong YK; Kim M; Kim WG
    Endocrinol Metab (Seoul); 2020 Sep; 35(3):618-627. PubMed ID: 32981304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas.
    Liu T; Wang N; Cao J; Sofiadis A; Dinets A; Zedenius J; Larsson C; Xu D
    Oncogene; 2014 Oct; 33(42):4978-84. PubMed ID: 24141777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of six ultrasound-based risk stratification systems in thyroid follicular neoplasm: A retrospective multi-center study.
    Yang J; Sun Y; Li X; Zhao Y; Han X; Chen G; Ding W; Li R; Wang J; Xiao F; Liu C; Xu S
    Front Oncol; 2022; 12():1013410. PubMed ID: 36338713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound-guided fine-needle aspiration or core needle biopsy for diagnosing follicular thyroid carcinoma?
    Park KW; Shin JH; Hahn SY; Oh YL; Kim SW; Kim TH; Chung JH
    Clin Endocrinol (Oxf); 2020 May; 92(5):468-474. PubMed ID: 32012326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conventional ultrasound characteristics, TI-RADS category and shear wave speed measurement between follicular adenoma and follicular thyroid carcinoma.
    Liu BJ; Zhang YF; Zhao CK; Wang HX; Li MX; Xu HX
    Clin Hemorheol Microcirc; 2020; 75(3):291-301. PubMed ID: 32280082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA.
    Wang N; Liu T; Sofiadis A; Juhlin CC; Zedenius J; Höög A; Larsson C; Xu D
    Cancer; 2014 Oct; 120(19):2965-79. PubMed ID: 24898513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.